Valley Medical Pharmacy 
630 Main Street 
Brawley, CA 92227 
eRx ID#0585957 
1 (800) 322-0808 | Toll Free Fax: 1 (855) 322-0808 
Email: drugsdepot@yahoo.com 
Web: www.drugsdepot 
Timing: Monday to Friday | 9:00 AM to 5:45 PM 


Veregen 15% Ointment 30 Gm By Pharmaderm Brand.

Image 0 of Veregen 15% Ointment 30 Gm By Pharmaderm Brand.Image 1 of Veregen 15% Ointment 30 Gm By Pharmaderm Brand.

Veregen 15% Ointment 30 Gm By Pharmaderm Brand.

Call for Price

Veregen 15% Ointment 30 Gm By Pharmaderm Brand. This Item Requires A Valid Order From A Physician Licensed in USA. Item Number.:RXB10111050/RXD4796546
Size : 30 GM
Selling UoM : EA
NDC: 10337-0450-03
UPC Barcode : 310337450035
Supplier: 0050001556 PHARMADERM BRANDED
Supplier Material : 045003
Generic Code : 063500 SINECATECHINS TOPICAL OINT. (G) 15 %
Fine Line Class : 850085008510 All Rx Products
Product Category : RX Pharmaceuticals
Product Type : BRX Branded RX

Have a question?

  Call for Price

Product Description.:

Ointment , brown

VEREGEN? is the first botanical drug approved for prescription use in the United States. It is made from the extract of green tea leaves. It's a powerful natural product that works hard to clear up your warts, but is gentler than many other treatment options.

It is proven to:

* Provide complete clearance of warts in most patients (53.6%)
* Offer a low rate (6.8%) of wart recurrence for patients who achieve complete clearance

VEREGEN? is also convenient?it's available in a 15 gram multidose tube that's easy to carry and store.

Important Product Safety Information

VEREGEN? Ointment, 15% is a medicine for skin use only (topical) for the treatment of warts on the outside of the genitals and around the outside of the anus. It is not a treatment for warts in the vagina, cervix, or inside the anus. Your doctor may recommend examination and screening tests (such as a Pap smear) to evaluate these areas.

VEREGEN? has not been evaluated to treat urethral, intra-vaginal, cervical, rectal, or intra-anal human papilloma viral disease and should not be used to treat these conditions. Avoid use of VEREGEN? on open wounds. Do not expose skin that has been treated with VEREGEN? to the sun or ultraviolet light because VEREGEN? has not been tested in these conditions. Safety and efficacy of VEREGEN? have not been established in immunosuppressed or pediatric patients, or pregnant women, or for the treatment of external genital and perianal warts beyond 16 weeks or for multiple treatment courses.

The most common adverse reactions that occurred in more than 20% of patients in studies with VEREGEN? were reactions of the skin and application site. These included reddening of the skin, itching, burning, pain or discomfort, skin ulcers, wearing down of the skin, swelling, hard spots, and rash with blisters.

Click Here for Prescribing Information